Compared to the control tissues, glioma tissues had a decreased expression of RAB3A, SYP, CAMK2A, and GABRA1 but an increased expression of TYROBP and VSIG4 (Figures 7(a)–7(f)). The gene discussed is CAMK2A; the disease is central nervous system cancer.